Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial. | BMJ Open | 2023 | 36898751 | PubTator, text mining | PubMed |
| Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance. | Nat Commun | 2023 | 36894562 | PubTator, text mining | PubMed |
| Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer. | Front Immunol | 2023 | 36891298 | PubTator, text mining | PubMed |
| ATM-dependent phosphorylation of CHD7 regulates morphogenesis-coupled DSB stress response in fetal radiation exposure. | Mol Biol Cell | 2023 | 36884301 | PubTator, text mining | PubMed |
| LncRNA HOTAIRM1 functions in DNA double-strand break repair via its association with DNA repair and mRNA surveillance factors. | Nucleic Acids Res | 2023 | 36881772 | PubTator, text mining | PubMed |
| SLFN5-mediated chromatin dynamics sculpt higher-order DNA repair topology. | Mol Cell | 2023 | 36854302 | PubTator, text mining | PubMed |
| Using biological constraints to improve prediction in precision oncology. | iScience | 2023 | 36852282 | PubTator, text mining | PubMed |
| Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia. | Cell Rep | 2023 | 36848231 | PubTator, text mining | PubMed |
| Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. | Signal Transduct Target Ther | 2023 | 36843114 | PubTator, text mining | PubMed |
| Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | Int J Mol Sci | 2023 | 36835656 | PubTator, text mining | PubMed |
| Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products. | Int J Mol Sci | 2023 | 36835100 | PubTator, text mining | PubMed |
| The Chromatin Landscape around DNA Double-Strand Breaks in Yeast and Its Influence on DNA Repair Pathway Choice. | Int J Mol Sci | 2023 | 36834658 | PubTator, text mining | PubMed |
| c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53. | Cancers (Basel) | 2023 | 36831504 | PubTator, text mining | PubMed |
| Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity. | Cells | 2023 | 36831326 | PubTator, text mining | PubMed |
| PD-1/PD-L1 and DNA Damage Response in Cancer. | Cells | 2023 | 36831197 | PubTator, text mining | PubMed |
| Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma. | Front Oncol | 2023 | 36816926 | PubTator, text mining | PubMed |
| Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics. | Nat Commun | 2023 | 36813776 | PubTator, text mining | PubMed |
| A novel DNA double-strand breaks biosensor based on fluorescence resonance energy transfer. | Biomater Res | 2023 | 36803668 | PubTator, text mining | PubMed |
| Emerging Roles of RNF168 in Tumor Progression. | Molecules | 2023 | 36771081 | PubTator, text mining | PubMed |
| DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival. | Int J Mol Sci | 2023 | 36769087 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=13